Seoul National University Bundang Hospital (SNUBH)
Glioma treatment cost in the Republic of Korea typically begins with a consultation with an oncologist ranging from $27 to $100, while primary surgical options like a craniotomy run from $16,500 to $38,000. Total expenses depend on the tumor stage, hospital tier, and necessity for specialized radiation like Gamma Knife, which costs $13,500 to $19,200. Patients often see 30-50% savings compared to the US. Top treatment centers are located in Seoul.
Typical Glioma Treatment Costs in Republic of Korea
Bookimed Expert Insight: Patients seeking high-precision care should prioritize Seoul's digitalized "Big 5" hospitals. Seoul National University Hospital (SNUH) is ideal for complex cases. It reports the highest cancer treatment statistics in the country. For error-prevention, SNUBH uses the BESTcare digital system. Severance Hospital offers JCI-accredited safety for international neurosurgery patients. Korea University Anam Hospital is best for those requiring advanced robotic-assisted surgical techniques.
| Republic of Korea | Turkey | Austria | |
| Gamma Knife | from $13,500 | from $6,300 | from $32,000 |
| Craniotomy | from $16,500 | from $5,650 | from $20,000 |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Stereotaxic radiosurgery | - | from $4,500 | from $17,000 |
| Resection of glioma | - | from $22,200 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Glioma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Glioma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Glioma treatment journey.
The doctor is a leading neurologist in South Korea, specializing in epilepsy treatment. Currently, the doctor serves as the Head of the Neurology Department at Yonsei Severance Hospital.
The doctor graduated from Yonsei University College of Medicine and is an active member of several professional organizations, including The Korean Epilepsy Society, The Korean Neurological Association, and The Korea Medical Association.
The doctor is a prominent figure in the field of surgery, holding leadership roles such as Director of the Training and Education Committee at the Korean Surgical Society and Director of the Information Technology Committee at the Korean Society of Coloproctology. The doctor also serves as Director of the Surgical Affairs Board at the Korean Society of Gastroenterology and Vice President of the Korean Association of Robotic Surgeons.
With a robust educational background from Korea University, the doctor has demonstrated surgical expertise internationally, including at the Faculty of Medicine, Chinese University of Hong Kong, and Tan Tock Seng Hospital in Singapore.
Seoul National University Hospital (SNUH), Asan Medical Center, and Severance Hospital are the top facilities for glioma treatment in Korea. These JCI-accredited and Newsweek-ranked centers utilize Gamma Knife and multidisciplinary brain tumor teams. They focus on maximal safe resection and precise molecular pathology testing.
Bookimed Expert Insight: While prestigious names like SNUH are popular, Gangnam Severance provides specialized neurosurgery within a more accessible setting. Data shows that major Korean tertiary centers serve millions of patients. This makes speed of admission a critical factor. For glioma, choosing a JCI-accredited facility that can quickly assemble a surgical team often outweighs the hospital brand name alone.
Patient Consensus: Patients emphasize finding a surgeon who handles high volumes of glioma cases rather than just picking a famous hospital. They recommend requesting a second pathology review to ensure the treatment plan matches the specific tumor grade.
South Korea offers high-precision glioma treatments including heavy ion therapy, Gamma Knife radiosurgery, and natural killer cell immunotherapy. JCI-accredited centers in Seoul utilize molecular profiling to customize chemotherapy. These facilities combine advanced neurosurgery with targeted radiation to maximize survival rates for complex brain tumors.
Bookimed Expert Insight: While many countries offer standard neurosurgery, Seoul's major centers like Asan Medical Center and Severance Hospital handle massive volumes. Asan alone sees over 2,500 inpatients daily. This scale allows these institutions to maintain specialized neuro-oncology teams that focus exclusively on rare glioma subtypes. Choosing a high-volume academic center ensures access to molecular testing, which is now essential for selecting the correct chemotherapy protocol.
Patient Consensus: Patients emphasize that successful treatment revolves around finding a major Seoul hospital capable of coordinating surgery, radiation, and pathology together. Many note that quick access to molecular profiling at these centers was key to their personalized care plan.
Foreign patients can join glioma clinical trials in the Republic of Korea. Major academic centers like Severance Hospital and Asan Medical Center recruit international participants for Phase 2 and 3 studies. Eligibility depends on meeting strict medical criteria and often requires self-funding for experimental protocols.
Bookimed Expert Insight: Data shows Korean university hospitals manage massive patient volumes, with Severance Hospital seeing 1.6 million outpatients annually. This high turnover fuels rapid clinical trial recruitment and deep technical expertise. Patients should prioritize hospitals with recent Newsweek rankings and JCI accreditation to ensure the highest safety standards during experimental treatments.
Patient Consensus: Patients note that trial access is not open tourism and requires meeting strict research protocols. Frequent follow-up visits and imaging mean participants must plan for long-term stays in Seoul.
South Korea reports a 5-year survival rate of 40% to 49% for unspecified gliomas. This matches the survival rates found in the United States and Norway. Major Korean centers utilize Gamma Knife and craniotomy within JCI-accredited facilities to maintain these global outcomes.
Bookimed Expert Insight: Korea excels in high-volume surgical efficiency. Asan Medical Center alone handles over 65,000 operations annually. This massive scale often leads to faster scheduling than in Western Europe. Swift intervention is a critical factor for glioma outcomes.
Patient Consensus: Patients note that Korean hospitals provide world-class surgical care and coordinated oncology. Success is often attributed to the skill of high-volume neuro-oncology teams.
Surgical resection for glioma in South Korea typically occurs within 2 to 4 weeks after the initial neurosurgical consultation. Urgent cases involving significant edema or neurological deficits may be fast-tracked for admission. Treatment often begins immediately with steroids or anti-seizure medications to stabilize the patient before surgery.
Bookimed Expert Insight: Speed depends on choosing high-capacity centers. Severance Hospital and Asan Medical Center manage thousands of daily outpatients. Our data shows these facilities integrate pathology and neurosurgery rapidly. This coordination allows international patients to shave 10 or more days off the standard diagnostic timeline compared to smaller clinics.
Patient Consensus: Patients note that arriving with MRI disks rather than just reports speeds up the process. They emphasize that starting steroids immediately often provides quick relief while waiting for the surgical team to finalize the plan.
South Korean neuro-oncology departments provide professional medical interpreters for non-Korean-speaking patients. Major JCI-accredited facilities in Seoul offer dedicated international patient centers. These coordinators manage communication for complex glioma treatments, including Gamma Knife and craniotomy. Support typically covers English, Chinese, Arabic, and Russian.
Bookimed Expert Insight: Data shows that Severance and Asan Medical Center serve thousands of international patients annually. While many staff speak basic English, neuro-oncology discussions require high medical nuance. Choosing a JCI-accredited facility ensures that professional interpreters are available for critical surgical planning. This prevents reliance on basic terminology during complex brain tumor consultations.
Patient Consensus: Patients emphasize that contacting the international office weeks before arrival is essential. They note that having a medical interpreter present during the consent process provides vital peace of mind.
Proton therapy for glioma is primarily performed at major tertiary cancer centers in Seoul and Gyeonggi-do. Leading institutions include the National Cancer Center in Goyang and Samsung Medical Center. Both facilities utilize advanced proton beam technology to treat aggressive brain tumors like glioblastomas and astrocytomas.
Bookimed Expert Insight: While several hospitals like Seoul National University Hospital (SNUH) and Severance Hospital have top oncology ratings, proton therapy remains concentrated in specific centers. Asan Medical Center performs over 65,000 operations yearly. This high surgical volume often serves as the initial stage before radiation begins.
Patient Consensus: Patients note that major university hospitals require prior MRI and pathology records for review. They emphasize checking if a center’s neuro-oncology board approves proton therapy before traveling.